Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Viewpoints: Medicare may be unintended victim of bank crisis; Health care industry's fears of law's reversal

The banks' actions led directly to an increase in government debt, which in turn has made the reduction of that debt by "cutting runaway spending" a centerpiece of the Republican presidential campaign to date.

12 Apr 2012

Newer antidepressant decreases depression in Parkinson's patients without worsening motor problems

Certain antidepressants appear to decrease depression in people with Parkinson's disease without worsening motor problems, according to a study published in the April 11, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

12 Apr 2012

AFAR to distribute nearly $2.5 million in career development awards

The American Federation for Aging Research (AFAR) announced today it will distribute nearly $2.5 million in career development awards to 83 advanced fellows and junior faculty members at 28 Hartford Centers of Excellence in Geriatric Medicine and Training.

12 Apr 2012

Number of people worldwide with dementia expected to triple by 2050; Caregivers need support, report says

The number of people living with dementia is expected to double to 65.7 million by 2030 and more than triple by 2050, with "the current estimated cost of treating and caring for those with the condition at $604 billion a year," according to a report released Wednesday by the WHO and Alzheimer's Disease International, Agence France-Presse reports.

12 Apr 2012

Preliminary results from GE Healthcare’s flutemetamol Phase 3 studies on AD

GE Healthcare today announced the preliminary results of two Phase 3 studies of its investigational PET amyloid imaging agent, [18F]flutemetamol, where both studies met their primary endpoints. One study, in terminally ill patients who agreed to undergo brain autopsy, showed strong concordance between flutemetamol PET images and Alzheimer's disease-associated beta amyloid brain pathology.

12 Apr 2012

Dementia burden on the Australian economy raises concerns

The report by the World Health Organization and Alzheimer's Disease International added that policy priorities should include raising awareness of the disease ensuring timely diagnosis. It estimates the global cost of dementia is more than $600 billion per year.

11 Apr 2012

Computer modeling supports theory that many dementias spread like prion diseases

A new technique for analyzing brain images offers the possibility of using magnetic resonance imaging (MRI) to predict the rate of progression and physical path of many degenerative brain diseases, report scientists at the San Francisco VA Medical Center and the University of California, San Francisco.

11 Apr 2012

Amyloid precursor protein appears to regulate its own production

A research team led by the University of South Florida Department of Psychiatry & Behavioral Neurosciences has found that a fragment of the amyloid precursor protein (APP) -- known as sAPP-α and associated with Alzheimer's disease -- appears to regulate its own production.

11 Apr 2012

New 4th Edition of Practical Neurology for clinicians, residents and fellows

The new 4th Edition of Practical Neurology, the respected "real-life" guide to diagnosing and managing neurologic disorders, has been completely rewritten to known neurologist and chair of the Department of Neurology of Loyola University Chicago Stritch School of Medicine.

11 Apr 2012

Lauren Sciences, BGN Technologies sign licensing agreement for V-Smart- drug delivery technology

BGN Technologies, the technology transfer company for Ben-Gurion University of the Negev (BGU), has signed a licensing agreement for its V-Smart- drug delivery technology with Lauren Sciences LLC, a privately held biotechnology company in New York.

11 Apr 2012

Siemens announces integrated imaging solution for detection of amyloid plaques

Siemens Healthcare is the first company worldwide to announce a complete integrated diagnostic imaging solution proposed for the detection of amyloid plaques — one of the necessary pathological features of Alzheimer's disease— in the living brain.

From Siemens Healthineers 11 Apr 2012

New report calls on nations to recognise dementia as a public health crisis

A report released today by the World Health Organization (WHO) and Alzheimer's Disease International (ADI) calls for governments and policymakers to make dementia a global public health priority.

11 Apr 2012

Reducing iron levels in blood plasma may protect brain from changes related to AD

Alzheimer's disease (AD) is now the sixth leading cause of death among Americans, affecting nearly 1 in 8 people over the age of 65. There is currently no treatment that alters the course of this disease. However, an increasing amount of evidence suggests that changes in the way the body handles iron and other metals like copper and zinc may start years before the onset of AD symptoms. A new study shows that reducing iron levels in blood plasma may protect the brain from changes related to AD.

11 Apr 2012

Avid Radiopharmaceuticals receives FDA approval for Amyvid to treat AD

The U.S. Food and Drug Administration today approved Amyvid (Florbetapir F 18 Injection) a drug for Positron Emission Tomography (PET) imaging of the brain in adults who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline.

11 Apr 2012

Two CNVs may increase risk of aggressive prostate cancer

An international research team led by Weill Cornell Medical College investigators have discovered two inherited-genetic deletions in the human genome linked to development of aggressive prostate cancer.

10 Apr 2012

Dementia sufferers and caregivers unhappy with quality of care

Dementia patients and their families have been asked to assess the quality of care available to them. Their reports are far from satisfactory. Alzheimer's Australia says dementia patients and their carers are being let down right across the health system. The Federal Government has promised to use the report to help decide how to improve the system.

9 Apr 2012

Berries may reduce Parkinson’s disease risk in men: Study

A new study has found that men who regularly consume foods rich in flavonoids, such as berries, apples, certain vegetables, tea and red wine, may significantly reduce their risk for developing Parkinson's disease. The study was published in the journal Neurology this week. It added that there was no such effect among women.

9 Apr 2012

FDA approves scan to detect Alzheimer’s disease early

The test uses a chemical called florbetapir, known by the brand name Amyvid, which is a radioactive agent that tags clumps of a sticky substance called an amyloid. Amyloid proteins are hallmarks of Alzheimer's disease. The chemical, which costs $1,600 per dose, then is detected using a brain imaging technique called positron emission tomography, known as PET scans. For patients who already have some symptoms of cognitive decline, a positive scan suggests that moderate to frequent amyloid plaques are present in the brain, which is consistent with Alzheimer's disease.

9 Apr 2012

Nuron Biotech licenses DNA amyloid beta 42 vaccine for AD

Nuron Biotech, Inc. today announced it has licensed from VITRUVIAN BioMedical, Inc. a gene-based (DNA) amyloid beta 42 (Aβ42) vaccine in preclinical development for Alzheimer's disease (AD).

9 Apr 2012

Free brain health screenings at Sam's Club

Everyone forgets sometimes. A certain degree of memory problems are a common part of aging. There is a difference, however, between changes in memory and memory loss from Alzheimer's disease. One in eight adults over the age of 65 is diagnosed with Alzheimer's, and 20 percent of the elderly population suffers from some form of dementia. If detected early, some memory loss can be manageable by taking simple steps to improve brain function.

7 Apr 2012